Calithera Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Calithera Biosciences generated cash of -$43,608,000, which is more than the previous year. Cash used in financing activities reached the amount of $9,655,000 last year. Net change in cash is therefore -$34,086,000.
Cash Flow
| 2013 | -11.83M | -173K | 43.62M |
|---|---|---|---|
| 2014 | -19.23M | -486K | 87.86M |
| 2015 | -29.93M | -66.77M | 845K |
| 2016 | -31.02M | 23.70M | 11.81M |
| 2017 | 13.75M | -98.82M | 122.94M |
| 2018 | -64.84M | 52.79M | 14.62M |
| 2019 | -78.74M | -10.78M | 98.90M |
| 2020 | -84.31M | 88.96M | 42.06M |
| 2021 | -66.3M | 7.85M | 10.66M |
| 2022 | -43.60M | -133K | 9.65M |
CALA Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 59.80M | 107.58M | 60.87M | 51.49M | 48.91M | 10.60M | 6.10M | 101.96M | 33.82M | 2.20M |
Operating activities | ||||||||||
Net income | -39.65M | -115.08M | -90.13M | -89.86M | -54.62M | -27.82M | -38.00M | -32.64M | -21.71M | -12.37M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 255K | 280K | 364K | 479K | 505K | 365K | 297K | 404K | 361K | 281K |
Stock-based compensation expense | 4.03M | 10.26M | 8.06M | 6.46M | 0 | 5.53M | 4.25M | 3.27M | 689K | 70K |
| Deferred income tax benefit | 4.03M | 10.26M | 8.06M | 6.46M | 0 | 5.53M | 4.25M | 3.27M | 689K | 70K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 1.51M | -855K | -1.14M | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 1.08M | 5.01M | 3.98M | 0 | 0 | 0 | 0 |
Accounts payable | -2.91M | 1.65M | -58K | 816K | 175K | 674K | -28K | -131K | 543K | 125K |
Cash generated by operating activities | -43.60M | -66.3M | -84.31M | -78.74M | -64.84M | 13.75M | -31.02M | -29.93M | -19.23M | -11.83M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | -57.05M | -153.22M | -76.10M | -194.65M | -44.61M | -109.09M | 0 | 0 |
Investments In Property Plant And Equipment | -133K | -147K | -61K | -7K | -214K | -1.22M | -401K | -441K | -556K | -164K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | -23.70M | 0 | 0 | 0 |
Cash generated by investing activities | -133K | 7.85M | 88.96M | -10.78M | 52.79M | -98.82M | 23.70M | -66.77M | -486K | -173K |
Financing activities | ||||||||||
Common Stock Issued | 9.63M | 10.66M | 40.86M | 97.68M | 13.70M | 121.61M | 11.28M | 0 | 71.62M | 65K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 9.65M | 10.66M | 42.06M | 98.90M | 14.62M | 122.94M | 11.81M | 845K | 87.86M | 43.62M |
Net Change In Cash | -34.08M | -47.77M | 46.70M | 9.37M | 2.58M | 37.87M | 4.49M | -95.86M | 68.14M | 31.61M |
Cash at end of period | 25.72M | 59.80M | 107.58M | 60.87M | 51.49M | 48.47M | 10.60M | 6.10M | 101.96M | 33.82M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |